Genetic and phenotypic findings in 34 novel Spanish patients with DDX3X neurodevelopmental disorder
Clinical Genetics · 2024
DOI: 10.1111/cge.14440 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Genetics, 2024. Verfasst von Alejandro Parra und 11 weiteren Autor:innen. Beteiligte Einrichtung: Group U753, CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid, Spain. Hauptthemen laut MEDLINE: Neurodevelopmental Disorders, Intellectual Disability, Nervous System Malformations, Brain Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: ISCIII with funding from FEDER, Europe.
Abstract (Originalsprache)
DDX3X is a multifunctional ATP‐dependent RNA helicase involved in several processes of RNA metabolism and in other biological pathways such as cell cycle control, innate immunity, apoptosis and tumorigenesis. Variants in DDX3X have been associated with a developmental disorder named intellectual developmental disorder, X‐linked syndromic, Snijders Blok type (MRXSSB, MIM #300958) or DDX3X neurodevelopmental disorder (DDX3X‐NDD). DDX3X‐NDD is mainly characterized by intellectual disability, brain abnormalities, hypotonia and behavioral problems. Other common findings include gastrointestinal abnormalities, abnormal gait, speech delay and microcephaly. DDX3X‐NDD is predominantly found in females who carry de novo variants in DDX3X . However, hemizygous pathogenic DDX3X variants have been also found in males who inherited their variants from unaffected mothers. To date, more than 200 patients have been reported in the literature. Here, we describe 34 new patients with a variant in DDX3X and reviewed 200 additional patients previously reported in the literature. This article describes 34 additional patients to those already reported, contributing with 25 novel variants and a deep phenotypic characterization. A clinical review of our cohort of DDX3X‐NDD patients is performed comparing them to those previously published.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Group U753, CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid, Spain.
- INGEMM-Idipaz, Institute of Medical and Molecular Genetics, Madrid, Spain.
- ITHACA, European Reference Network, Hospital Universitario La Paz, Madrid, Spain.
- Unidad de Genética Adultos, Hospital Guillermo Grant Benavente, Concepción, Chile.
- Unidad de Diagnóstico Molecular y Genética Clínica, Hospital Universitario Son Espases, Idisba, Palma de Mallorca, Spain.
- Spanish OverGrowth Registry Initiative, La Paz University Hospital, Madrid, Spain.
ORCID-Profile: Pablo Lapunzina
Förderung
- ISCIII with funding from FEDER, Europe
Zitieren
APA
Parra, A., Pascual, P., Cazalla, M., Arias, P., Gallego-Zazo, N., San-Martín, E. A., Silván, C., Santos-Simarro, F., Spanish OverGrowth Registry Initiative (SOGRI), Nevado, J., Tenorio-Castano, J., & Lapunzina, P. (2024). Genetic and phenotypic findings in 34 novel Spanish patients with DDX3X neurodevelopmental disorder. Clinical Genetics. https://doi.org/10.1111/cge.14440
Vancouver
Parra A, Pascual P, Cazalla M, Arias P, Gallego-Zazo N, San-Martín EA, et al. Genetic and phenotypic findings in 34 novel Spanish patients with DDX3X neurodevelopmental disorder. Clinical Genetics. 2024. doi:10.1111/cge.14440
BibTeX
@article{Parra2024,
author = {Parra, Alejandro and Pascual, Patricia and Cazalla, Mario and Arias, Pedro and Gallego-Zazo, Natalia and San-Martín, Esteban A and Silván, Cristina and Santos-Simarro, Fernando and Spanish OverGrowth Registry Initiative (SOGRI), Spanish OverGrowth Registry Initiative (SOGRI) and Nevado, Julián and Tenorio-Castano, Jair and Lapunzina, Pablo},
title = {Genetic and phenotypic findings in 34 novel Spanish patients with DDX3X neurodevelopmental disorder},
journal = {Clinical Genetics},
year = {2024},
doi = {10.1111/cge.14440}
}
EUVIMED